ATE478095T1 - Konjugate mit einem für die ed-b-domäne von fibronectin spezifischen antikörper, und deren verwendung zum nachweis und zur behandlung von tumoren - Google Patents
Konjugate mit einem für die ed-b-domäne von fibronectin spezifischen antikörper, und deren verwendung zum nachweis und zur behandlung von tumorenInfo
- Publication number
- ATE478095T1 ATE478095T1 AT03726977T AT03726977T ATE478095T1 AT E478095 T1 ATE478095 T1 AT E478095T1 AT 03726977 T AT03726977 T AT 03726977T AT 03726977 T AT03726977 T AT 03726977T AT E478095 T1 ATE478095 T1 AT E478095T1
- Authority
- AT
- Austria
- Prior art keywords
- fibronectin
- domain
- conjugates
- detecting
- antibodies specific
- Prior art date
Links
- 102000016359 Fibronectins Human genes 0.000 title abstract 2
- 108010067306 Fibronectins Proteins 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02000315 | 2002-01-03 | ||
| US35870202P | 2002-02-25 | 2002-02-25 | |
| PCT/EP2003/000009 WO2003055917A2 (en) | 2002-01-03 | 2003-01-02 | Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE478095T1 true ATE478095T1 (de) | 2010-09-15 |
Family
ID=35976951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03726977T ATE478095T1 (de) | 2002-01-03 | 2003-01-02 | Konjugate mit einem für die ed-b-domäne von fibronectin spezifischen antikörper, und deren verwendung zum nachweis und zur behandlung von tumoren |
Country Status (8)
| Country | Link |
|---|---|
| KR (2) | KR20100077052A (de) |
| AT (1) | ATE478095T1 (de) |
| DE (1) | DE60333820D1 (de) |
| DK (1) | DK1461360T3 (de) |
| ES (1) | ES2346750T3 (de) |
| PT (1) | PT1461360E (de) |
| SI (1) | SI1461360T1 (de) |
| ZA (1) | ZA200406162B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3691771B1 (de) | 2017-10-02 | 2023-08-16 | Battelle Energy Alliance, LLC | Verfahren und systeme zur elektrochemischen reduktion von kohlendioxid unter verwendung von umschaltbaren polaritätsmaterialien |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI259837B (en) * | 1998-05-11 | 2006-08-11 | Eidgenossische Tech Hochscule | Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
-
2003
- 2003-01-02 ES ES03726977T patent/ES2346750T3/es not_active Expired - Lifetime
- 2003-01-02 AT AT03726977T patent/ATE478095T1/de not_active IP Right Cessation
- 2003-01-02 KR KR1020107013008A patent/KR20100077052A/ko not_active Application Discontinuation
- 2003-01-02 SI SI200331895T patent/SI1461360T1/sl unknown
- 2003-01-02 DK DK03726977.6T patent/DK1461360T3/da active
- 2003-01-02 PT PT03726977T patent/PT1461360E/pt unknown
- 2003-01-02 DE DE60333820T patent/DE60333820D1/de not_active Expired - Lifetime
- 2003-01-02 KR KR1020047010498A patent/KR100998803B1/ko not_active IP Right Cessation
-
2004
- 2004-08-02 ZA ZA200406162A patent/ZA200406162B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI1461360T1 (sl) | 2010-12-31 |
| DE60333820D1 (de) | 2010-09-30 |
| ES2346750T3 (es) | 2010-10-20 |
| ZA200406162B (en) | 2005-09-27 |
| KR20040073540A (ko) | 2004-08-19 |
| KR20100077052A (ko) | 2010-07-06 |
| DK1461360T3 (da) | 2010-11-15 |
| KR100998803B1 (ko) | 2010-12-06 |
| PT1461360E (pt) | 2010-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04006517A (es) | Conjugados que comprenden un anticuerpo especifico para el dominio ed-b de fibronectina y sus usos para la deteccion y tratamiento de tumores. | |
| ATE443260T1 (de) | Kontrastmittel und verfahren zum imaging von naaldase oder psma | |
| CY1120924T1 (el) | Αντισωματα εναντι-αλφα v βητα 6 και χρησεις αυτων | |
| RS80704A (en) | ANTI- av?6.ANTIBODIES | |
| CY1118566T1 (el) | Διαγνωση με χρηση ιντερφερονης τυπου 1 | |
| TW200626900A (en) | Wnt proteins and detection and treatment of cancer | |
| DE60130538D1 (de) | Humanisierte antikörper gegen ccr2 und verfahren zur deren verwendung | |
| BRPI0613382A8 (pt) | anticorpos isolados, anticorpo monoclonal, célula de hibridoma, método de identificação, método de inibição do crescimento de uma célula, método de tratamento terapêutico, método de determinação da presença de uma proteína, métodos de diagnósticos da presença de tumor | |
| DE69942742D1 (de) | Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs | |
| NZ594466A (en) | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies | |
| ATE403001T1 (de) | Antigenbindungsfragmente die spezifisch krebszellen nachweisen, nukleotide die für diese fragmente kodieren, und deren verwendung zur vorbeugung und zum nachweis von krebs | |
| NO20072721L (no) | Polypeptides that bind BR3 and uses thereof | |
| EA200800094A1 (ru) | Антитела cd19 и их использование | |
| ATE459653T1 (de) | Monoklonale anti-cd71-antikörper und deren verwendung zur behandlung maligner tumorzellen | |
| ATE492563T1 (de) | Vollständige humane monoklonale antikörper gegen il-13 | |
| SG170793A1 (en) | Anti-mn antibodies and methods of using same | |
| DE602005027399D1 (de) | Für humane matriptase spezifische bindungsproteine | |
| ATE526037T1 (de) | Verfahren zum abtöten von tumorzellen mittels targeting von auf apoptotischen tumorzellen exponierten internen antigenen | |
| ATE412756T1 (de) | Verfahren zur krebsdiagnose mittels eines chimärischen toxin | |
| ATE466031T1 (de) | Anti-hgf-r-antikörper und deren verwendung | |
| ATE540676T1 (de) | Egfr-inhibitoren zur behandlung und diagnose von metastasierendem prostatakrebs | |
| BRPI0407680A (pt) | métodos para diagnóstico de cáncer e diminuição de metástase por células cancerosas | |
| MX2021009975A (es) | Anticuerpos de cd33 y métodos para usar los mismos para tratar el cáncer. | |
| ATE553127T1 (de) | Oligoklonale anti-clusterin-antikörper zur diagnose und vorhersage der aggressivität von tumoren, diagnostisches verfahren und damit in zusammenhang stehende kits | |
| MXPA05011085A (es) | Composiciones y metodos relacionados a stop-1. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1461360 Country of ref document: EP |
|
| EELV | Lapsed due to withdrawal | ||
| REZ | Deleted due to withdrawal |